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Abstract: Genomic imprinting, an epigenetic phenomenon that causes the expression of a small
set of genes in a parent-of-origin-specific manner, is thought to have co-evolved with placentation.
Many imprinted genes are expressed in the placenta, where they play diverse roles related to
development and nutrient supply function. However, only a small number of imprinted genes
have been functionally tested for a role in nutrient transfer capacity in relation to the structural
characteristics of the exchange labyrinthine zone. Here, we examine the transfer capacity in a mouse
model deficient for the maternally expressed Phlda2 gene, which results in placental overgrowth
and a transient reduction in fetal growth. Using stereology, we show that the morphology of the
labyrinthine zone in Phlda2−/+ mutants is normal at E16 and E19. In vivo placental transfer of
radiolabeled solutes 14C-methyl-D-glucose and 14C-MeAIB remains unaffected at both gestational
time points. However, placental passive permeability, as measured using two inert hydrophilic
solutes (14C-mannitol; 14C-inulin), is significantly higher in mutants. Importantly, this increase in
passive permeability is associated with fetal catch-up growth. Our findings uncover a key role played
by the imprinted Phlda2 gene in modifying placental passive permeability that may be important for
determining fetal growth.
Keywords: Phlda2; genomic imprinting; placenta; fetal growth; passive permeability
1. Introduction
Genomic imprinting is an epigenetic phenomenon that leads to allele-specific expres-
sion depending on the parent-of-origin of the allele [1]. Genomic imprinting is thought
to have evolved independently in flowering plants with endosperm and in placental
mammals, both of which have specialist structures to support the development of the
offspring [2]. In mammals, there is an evolutionary link between genomic imprinting and
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placentation, strongly supporting the hypothesis that imprinted genes play key roles in
allocation of maternal resources via the placenta. Reinforcing the notion that imprinted
genes have a special role in placental biology, a large proportion of the approximately 100
imprinted genes identified to date in mice and humans are highly expressed in the pla-
centa [3]. Additionally, mouse models of loss-of-imprinting, leading to either reactivation
of the silent allele or silencing of the active allele, have uncovered a number of placental
phenotypes, ranging from abnormal growth and structure to changes in placental transfer
capacity and endocrine function (reviewed by [4–6]).
Phlda2 (pleckstrin homology-like domain family A member 2, also known as Ipl—
imprinted in placenta and liver) is a maternally expressed gene located in a cluster of
imprinted genes on distal chromosome 7 in the mouse, with shared synteny to the human
chromosome 11p15.5 region. During early mouse development, prior to gastrulation,
Phlda2 mRNA expression is restricted to the extra-embryonic ectoderm and the ectoplacen-
tal cone [7]. In the definitive placenta (from E10.5), expression of PHLDA2 at the mRNA
and protein level persists only in the labyrinthine trophoblast until mid-gestation. It then
declines markedly after E14.5, except in the chorionic plate [8,9]. Phlda2 expression is also
observed at high levels in the visceral yolk sac endoderm until mid-gestation. In fetal
tissues, Phlda2 mRNA levels are moderate in liver and considerably lower in kidney, lung
and limb [8]. In human placentae, PHLDA2 protein is highly expressed in the villous cy-
totrophoblast [10]. By contrast, low levels are present in the cytotrophoblast cells columns
of anchoring villi during early pregnancy and in the extravillous trophoblast derived from
them [9,10]. PHLDA2 protein consists of a single pleckstrin homology (PH) domain with
short N- and C-terminal extensions, which demonstrates binding to phosphatidylinosi-
tol phosphate (PIP) in vitro and is therefore likely involved in intracellular trafficking or
signaling [11]. By homology to mouse PHLDA1/TDAG51, PHLDA2 may play a role in
FAS-mediated apoptosis, which is consistent with a potential growth-inhibitory effect [12].
In mice, maternal deletion of the Phlda2 gene (Phlda2−/+) leads to placentomegaly,
with expansion of the junctional zone, independent of the genetic background [9,13,14].
Additionally, Phlda2−/+ leads to a transient reduction in fetal weight in late gestation on
the C57BL/6J genetic background [9,14] and to a global fetal growth restriction on the
129S2/SvHsd genetic background affecting both the wild-type and the mutant fetuses [13].
Within the junctional zone, Phlda2−/+ mutants have more glycogen stored and the expres-
sion of several placental hormone genes is increased [13]. Increased Phlda2 expression,
achieved by loss-of-imprinting or insertion of a single-copy transgene, results in placental
growth restriction, with loss of the spongiotrophoblast lineage and reduced placental
glycogen accumulation [14,15]. Additionally, elevated Phlda2 expression leads to asym-
metric fetal growth restriction [15,16]. In humans, the expression levels of PHLDA2 are
negatively correlated with birthweight [17], and are elevated in cases of fetal growth restric-
tion (FGR) [18–20]. Furthermore, maternal inheritance of a 15 bp variant at the PHLDA2
promoter region that reduces its activity leads to increased birth weight [21], further
demonstrating the importance of the finely balanced expression of this imprinted gene.
The overall aim of this study was to investigate the contribution of the placenta to
the transitory reduction in fetal growth observed in Phlda2−/+ mutants [9]. To achieve this
goal, we characterized the morphological and transfer properties of Phlda2−/+ placentae at
two stages of late gestation (E16 and E19). Specifically, we used stereological techniques to
establish the effects of Phlda2−/+ mutation on placental labyrinthine zone morphology and
to estimate placental diffusion capacity, as well as placental transfer assays to determine
placental transfer capacity related to passive permeability to hydrophilic solutes, facilitated
diffusion and active transport in vivo.
2. Materials and Methods
2.1. Mice
The IplloxP transgenic lines were produced elsewhere [9] and maintained in a C57BL/6J
background. In all experiments, the mutant alleles were transmitted by a heterozygous
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mother carrying the deleted allele on her paternal chromosome, crossed with C57BL/6J
wild-type males, giving the genotypes −/+ (subsequently called Phlda2−/+) and +/+
(subsequently called Phlda2+/+). Growth kinetics studies, placental transfer assays and
stereological analyses were performed in −/+ versus +/+ littermates. Mice were fed a
standard chow diet and housed with a 12 h light/dark cycle in a temperature-controlled
room (22 ◦C). For timed matings, the day of detection of a vaginal plug was noted as
embryonic day 1 (E1). All studies were performed at the embryonic days E16 and E19.
2.2. Genotyping
All genotyping was performed by PCR with DNA extracted from yolk sacks, using
the Expand High Fidelity PCR system (Roche) and standard cycling conditions according
to the manufacturer’s recommendations. Phlda2−/+ offspring were identified using primers:
Phlda2F: 5′-TCAAGCAATGGGTAAGGG-3′ and Phlda2R: 5′-TCCATCATTAGAGACAGCCA-
3′ to amplify a 362 bp fragment across the deletion, with an additional forward primer
(5′-GTTATTCCCTCTCCACATCC-3′) used to amplify a 639 bp product from the wild-type
alleles (annealing temperature is 55 ◦C).
2.3. Placental Stereology
Stereology was performed on placentae collected at E16 and E19 and undertaken
blinded to genotype. Placentae were hemisected using a double-edged razor blade, each
half weighed, and immediately fixed. The stereology analysis was performed according
to the protocol described previously [22]. Briefly, half of each placenta was fixed in 4%
paraformaldehyde and embedded in paraffin wax, sectioned and stained using a standard
hematoxylin and eosin protocol. The corresponding placental halves were fixed for 6 h
with 4% glutaraldehyde and embedded in resin, sectioned and stained with methylene
blue. The paraffin and resin-embedded counterparts were then analyzed using the Com-
puter Assisted Stereology Toolbox (CAST) 2.0 system from Olympus (Ballerup, Denmark).
The paraffin sections allow measurements for absolute placental volumes and volumes of
the three main placental zones (labyrinthine zone—Lz, junctional zone—Jz and decidua
basalis—Db) using the Cavalieri principle, as well as Jz/Lz volume ratios. Resin sections
allow for detailed measurements of the labyrinthine zone: volume of maternal blood spaces
(MBS), fetal capillaries (FC) and labyrinthine trophoblast (LT), the surface areas of the MBS
and FC and the thickness of the labyrinthine interhemal membrane (IMT), as well as calcu-
lating the theoretical diffusion capacity (TDC) and the specific diffusion capacity (SDC),
as described [22]. TDC indicates the potential of the labyrinthine interhemal membrane for
passive diffusion, and SDC is a measure of how effective the interhemal membrane of the
placenta is at meeting fetal needs [22].
2.4. Placental Transfer Assays of Radio-Labelled Solutes
Placental transfer assays (PTAs) were performed in pregnant heterozygous females
crossed with C57BL/6J males at E16 or E19 using the following radiolabeled tracers:
14C-mannitol, 14C-inulin-carboxyl and the non-metabolizable analogues, 14C-methyl-D-
glucose and 14C-methyl-aminoisobutyric acid (MeAIB; a specific substrate of System A
amino acid transporters). Details regarding PTAs have been described elsewhere [23,24].
Radioactive counts in each fetus (measured as DPM—disintegrations per minute) were
used to calculate the amount of radioisotope transferred per gram of Lz or per gram of
fetus. The weight of Lz was estimated by multiplying individual placental weights with
an average Lz percentage value determined by placental stereology for each genotype
and gestational stage (from 3 litters, as previous described for similar conversions [25]).
Average values for Phlda2+/+ controls and Phlda2−/+ mutant fetuses within a litter were
calculated and expressed as the Phlda2−/+/Phlda2+/+ ratio for that litter. These values
could be used to calculate a mean for all litters at E16 and E19. The fetal accumulation of
radioisotope expressed relative to Lz weight and plotted as the Phlda2−/+/Phlda2+/+ ratio
gives a relative measure of Lz transfer of the solute. The fetal accumulation of radioisotope
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expressed relative to fetal weight gives a relative measure of the amount of solute received
by the fetus.
2.5. Statistical Analysis
No explicit power analyses were used to predetermine sample size. All normally
distributed data were analyzed by means of two-way analyses of variance with “litters”
and “genotype” as the two factors. Data are expressed as means ± standard error of the
mean (SE). For data representing radioactive counts, a logarithmic transformation was
carried out before statistical analysis. The summary data from these experiments were
then presented as ratios, together with 95% confidence limits or as DPM/g Lz or DPM/g
fetus ± SE.
3. Results
3.1. Phlda2−/+ Mutants Show Placental Overgrowth Associated with Transitory Reduction in
Fetal Growth
Maternal inheritance of Phlda2−/+ deletion on the C57BL/6J genetic background led to
placental overgrowth and a transient reduction in fetal growth as previously reported [9,14].
Mutant placentae were on average ~129% of Phlda2+/+ littermates at both E16 and E19 of
gestation (Table 1) (p < 0.001), whereas there was a modest but significant reduction in fetal
weight to 96% at E16 (p < 0.05), which was lost by E19 (99%, p = NS, not significant). As a
result, the Phlda2−/+ mutants displayed decreased fetal-to-placental (F/P) weight ratios in
comparison to Phlda2+/+ control littermates (Table 1).
Table 1. Fetal weights, placental weights and F/P weight ratios for Phlda2−/+ mutants and Phlda2+/+ controls.
Gestational Age Genotype N Fetal Wet Weight (g) ± SE Placental Wet Weight (g) ± SE F/P Weight Ratios ± SE
E16
Phlda2+/+ 48 0.398 ± 0.005 0.100 ± 0.002 4.007 ± 0.083
Phlda2−/+ 49 0.384 ± 0.005 0.129 ± 0.002 3.099 ± 0.081
(% of
Phlda2+/+) 96.4 * 129.7 *** 77.3 ***
E19
Phlda2+/+ 88 1.079 ± 0.009 0.082 ± 0.001 13.395 ± 0.227
Phlda2−/+ 94 1.069 ± 0.009 0.106 ± 0.001 10.247 ± 0.172
(% of
Phlda2+/+) 99.1 129.3 *** 76.5 ***
F/P weight ratios = Fetal wet weight/Placental wet weight. * p < 0.05; *** p < 0.001.
3.2. Placental Overgrowth in Phlda2−/+ Mutants Does Not Affect the Labyrinthine Zone
Next, we investigated whether the placental overgrowth, which was previously
reported to be restricted to the endocrine zone (or junctional zone), also affected the
transport zone (labyrinthine zone), by performing in-depth stereological analysis through-
out the whole of the placenta. The marginal increases in Lz volume (110% and 115% of
Phlda2+/+ littermates at E16 and E19, respectively) were not statistically significant (Table 2).
This finding is in contrast to the significant increases in absolute volume of the Jz to
222% and 155% of Phlda2+/+ control littermates at E16 and E19, respectively (p < 0.01).
As a result, the Jz/Lz ratio increased almost two-fold in Phlda2−/+ at E16 (p < 0.01), but was
similar between the two genotypes at E19 (129%; p = NS) (Table 2). The latter finding is
mainly due to the well-established changes in the proportions of the two zones near term
(i.e., a decrease in the junctional zone and an increase in the labyrinthine zone, as described
previously [22]).
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Table 2. Absolute volumes of components in the placenta of Phlda2−/+ mutants and Phlda2+/+ controls at two gestational





+/+ Phlda2−/+ % ofPhlda2+/+
Placenta 93.49 ± 3.215 139.36 ± 5.754 149 ** 88.73 ± 7.377 116.41 ± 1.677 131 *
Lz 40.71 ± 2.151 44.89 ± 1.575 110 44.13 ± 5.668 50.60 ± 2.122 115
Jz 32.14 ± 0.172 71.31 ± 8.042 222 ** 30.54 ± 1.176 47.26 ± 2.597 155 **
Db 18.13 ± 1.499 19.78 ± 4.538 109 11.07 ± 1.603 13.82 ± 1.535 125
Jz/Lz 0.80 ± 0.049 1.58 ± 0.138 198 ** 0.73 ± 0.110 0.94 ± 0.081 129
Values are mean ± SE volume (mm3); n = 9 per genotype at E16 and n = 6 per genotype at E19 from 3 litters/group; Lz—labyrinthine zone;
Jz—junctional zone; Db—decidua basalis; * p < 0.05; ** p < 0.01.
Within the Lz, further stereological analyses were made on resin sections, namely
absolute measurements of the transport epithelium: labyrinthine trophoblast (LT), maternal
blood spaces (MBS) and fetal capillaries (FC). Of these three Lz components (LT, MBS and
FC), only the volume of MBS was significantly increased in Phlda2−/+ placentae, specifically
at E19 (151%; p < 0.05) (Table 3). However, the surface areas occupied by MBS, LT, FC
were normal, as was the interhemal membrane thickness (IMT) at both E16 and E19
(Table 3). The theoretical diffusion capacity (TDC) and the specific diffusion capacity (SDC)
of the Phlda2−/+ placentae, which depend to a great extent on the IMT, were not altered
significantly at either E16 or E19 (Table 3). Thus, the Phlda2−/+ placentae have an enlarged
Jz, while the structure and size of the Lz compartment is normal, at least at the level of
resolution provided by light microscopy-based stereology.





+/+ Phlda2−/+ % ofPhlda2+/+
LT 26.07 ± 0.139 29.57 ± 1.418 113 28.92 ± 5.013 30.80 ± 1.059 107
MBS 7.37 ± 1.291 7.86 ± 1.156 107 7.47 ± 0.754 11.27 ± 0.938 151 *
FC 7.27 ± 1.384 7.45 ± 0.154 103 7.73 ± 1.565 8.52 ±1.469 110
MBS SA 18.40 ± 0.929 16.71 ± 2.075 91 22.28 ± 2.848 27.57 ± 2.182 124
FC SA 14.97 ± 1.351 15.78 ± 1.281 105 16.65 ± 3.058 19.86 ± 3.718 119
IMT 4.29 ± 0.373 4.25 ± 0.154 99 3.99 ± 0.185 4.08 ± 0.295 102
TDC 0.0069 ± 0.0006 0.0068 ± 0.0008 99 0.0085 ± 0.0011 0.0104 ± 0.0019 123
SDC 0.0205 ± 0.0020 0.0200 ± 0.0033 98 0.0072 ± 0.0007 0.0092 ± 0.0020 129
Values are mean ± SE; n = 9 per genotype at E16 and n = 6 per genotype at E19 from 3 litters/group; LT—labyrinthine trophoblast (mm3);
MBS—maternal blood spaces (mm3); FC—fetal capillaries (mm3); MBS SA—maternal blood spaces surface area (cm2); FC SA—fetal
capillaries surface area (cm2); IMT—interhemal membrane thickness of the labyrinthine zone (µm); TDC—theoretical diffusion capacity of
the interhemal membrane (cm2.min−1.kPa−1); SDC—specific diffusion capacity (cm2.min−1.kPa−1.g−1); * p < 0.05.
3.3. Phlda2−/+ Placentae Show Increased Passive Permeability to Hydrophilic Solutes
To investigate the exchange properties of the Phlda2−/+ placentae, we started by
assessing the diffusional characteristics using the inert tracers 14C-mannitol and 14C-inulin,
which can only cross the placenta by passive diffusion. Surprisingly, we found that the
overgrown Phlda2−/+ placenta had a pronounced increase in its passive permeability
relative to Phlda2+/+ controls, despite unaltered surface area of the Lz components and
normal IMT, TDC and SDC compared to wild-types. Accordingly, the amounts of 14C-
mannitol and 14C-inulin transferred per gram Lz were significantly increased to 154%
Genes 2021, 12, 639 6 of 13
and 156% of the Phlda2+/+ control values at E16, respectively (Figure 1A and Figure S1A).
Additionally, Phlda2−/+ placentae transferred increased amounts of the larger inert tracer
14C-inulin (134%; p < 0.01), but not 14C-mannitol, at E19 (Figure 1A and Figure S1A).
The accumulation of the two passive diffusion markers per gram of fetus was significantly
increased at both E16 and E19, i.e., Phlda2−/+ fetuses received an excess of the radioactive
labels for their size relative to Phlda2+/+ controls (Figure 1A and Figure S1A). These results
strongly suggest that the Phlda2−/+ placentae are more permeable to hydrophilic solutes
than Phlda2+/+ littermates at both gestational ages.
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Next, we investigated if other major transport processes, i.e., active transport and facil-
itated diffusion, were also affected in the Phlda2−/+ mutants, by assessing the in vivo flux
of representative tracers, 14C-MeAIB and 14C-methyl-D-glucose, respectively. We found
that the transfer of 14C-methyl-D-glucose per gram of Lz was similar between Phlda2−/+
and Phlda2+/+ at both E16 and E19 (Figure 1B and Figure S1B). Accumulation of 14C-methyl-
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D-glucose per gram of fetus was also similar between the two genotypes at both gestational
ages, i.e., mutant fetuses received an appropriate amount of 14C-methyl-D-glucose for
their size (Figure 1B and Figure S1B). Additionally, 14C-MeAIB transfer per gram of Lz
placenta and 14C-MeAIB accumulation per gram of fetus were normal at both E16 and E19
(Figure 1B and Figure S1B).
We conclude that maternal transmission of the Phlda2−/+ deletion leads to placentae
that are more permeable to hydrophilic solutes, leading to altered diffusional flux of such
solutes to and from the growing fetus. This alteration seems specific to passive permeability,
as transplacental flux by facilitated diffusion and active transport is normal at both E16
and E19.
4. Discussion
Maternal–fetal exchange by passive diffusion is responsible for a significant proportion
of the total solute flux across the hemochorial placenta and is therefore thought to be a
significant determinant of fetal growth [26,27]. Indeed, passive diffusion is responsible
for the transfer of water, ions, minerals and water-soluble vitamins needed for enzyme
activities [26]. This study uncovered a novel role for the imprinted Phlda2 gene as a putative
negative regulator of the diffusional permeability characteristics of the mouse placenta. Our
findings are based on measurements of the maternal–fetal transfer of two inert hydrophilic
molecules of increasing size (Dw values of 9.9 cm2/s × 106 and 2.6 cm2/s × 106 for 14C-
mannitol and 14C-inulin, respectively, see [23]) in Phlda2-deficient mice, which showed
significantly enhanced transfer during late gestation. Our study adds Phlda2 to the growing
list of imprinted genes with roles in the developmental regulation of diffusional exchange
characteristics of the placenta. To our knowledge, this study is the first to report the action
of an imprinted gene in determining maternal–fetal exchange of solutes solely by effects
on passive diffusion.
In this study, we set out to explore aspects related to the placental phenotype of the
Phlda2−/+ mouse model. First, the expression of Phlda2 is observed primarily in the tro-
phoblast cells within the Lz, but the placental phenotypes, including placental overgrowth,
were previously reported to be restricted to the Phlda2-non-expressing Jz. One of the objectives
of our study was, therefore, to investigate if the lack of normal Phlda2 expression in the
Lz had any functional impact in this layer, by performing in-depth stereological analyses
focused on the morphological characteristics of the Lz that determine transfer capacity.
Second, Phlda2−/+ mutation results in a modest and transitory reduction in fetal growth.
We wanted to establish if, and how, the placenta contributes to the fetal growth phenotype,
primarily by analyzing the trans-placental flux of nutrients and other solutes.
Consistent with previous findings in C57BL/6J genetic background [9], we found
that Phlda2−/+ conceptuses show overgrowth of the placenta by ~30% at both E16 and
E19. In our study, however, fetuses were approximately 4% lighter at E16 and of normal
weight by E19, whereas Frank et al. reported a higher degree of FGR, with fetuses ~13%
lighter at E17, with no data available at E19 or birth [9]. Based on our study alone,
these observations suggest that mutant Phlda2−/+ fetuses undergo an initial phase of
fetal growth retardation, followed by intra-uterine catch-up growth. Interestingly, on the
129S2/SvHsd genetic background, Phlda2−/+ fetuses did not show any weight difference
compared to their Phlda2+/+ littermate controls at E14.5, E16.5 and E18.5 [13]. Additionally,
placental overgrowth in Phlda2−/+ mutants was more pronounced on the 129S2/SvHsd
genetic background compared to the C57BL/6J genetic background, with a maximal
increase of 50% at E16.5 [13]. However, it was also observed that at E18.5 both Phlda2+/+
and Phlda2−/+ fetuses were about 15% lighter when compared to wild-type litters on the
129S2/SvHsd genetic background, demonstrating that Phlda2−/+ mutation is affecting
the phenotype in wild-type conceptuses of the same litter [13]. However, in our study,
Phlda2+/+ fetuses from mixed litters were of similar weight to those from wild-type litters
on the C57BL/6J genetic background collected subsequently, at both E16 (0.398 ± 0.005
(n = 48) versus 0.396 ± 0.003 (n = 70), p = 0.91) and E19 (1.079 ± 0.009 (n = 88) versus
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1.108 ± 0.011 (n = 37), p = 0.15). Our stereological analyses of the placental phenotype
confirmed that deletion of maternal Phlda2 allele leads to a disproportionate overgrowth
of placental Jz [9,13]. However, we also provide evidence that the structure of Lz was
remarkably normal, with the notable exception of maternal blood spaces that occupy a
larger volume at E19 in mutants. The finding that the structure of Lz was largely normal
was surprising, given that PHLDA2 expression is restricted to type III (fetal facing) and type
II (proliferating) trophoblast cells of Lz [9]. These findings taken together are consistent
with the suggestion that the overgrowth of Jz is controlled by signaling events taking
place in Lz by unknown mechanisms [9]. An alternative explanation is that Phlda2 limits the
expansion of progenitors contributing to the Jz, as previously proposed [15].
As described in detail elsewhere [23,28], the rate of transfer across the placenta of an
inert uncharged solute is described by Fick’s Law of diffusion and gives a measure of the
passive permeability. Thus, flux is determined directly by the surface area for exchange and
the maternal–fetal concentration gradient, and inversely by the thickness of the barrier and
the size of the molecule (usually determined by its diffusion coefficient in water at 37 ◦C).
Under the conditions of our experiments, where transfer was measured as a unidirectional
flux, the only variables expected to alter the transfer of the 14C-mannitol and 14C-inulin
would be the surface area available for exchange and/or the thickness of the exchange
barrier. Surprisingly, therefore, we measured an increase in the diffusional permeability of
these solutes in the absence of any change in the stereologically measured area or thickness
of the IMT, as well as TDC and SDC. However, the previously reported dependence of
diffusional transfer on the size of such hydrophilic solutes [23,27], which cannot easily cross
the hydrophobic plasma membrane, suggests that there must be an extracellular water-
filled route across the syncytiotrophoblast through which diffusion takes place. The nature
of this extracellular water-filled route is uncertain and its dimensions would likely differ
from that of the stereologically measured barrier surface area and thickness. In humans,
transtrophoblastic channels [29] and syncytial denudations [30] have been suggested as
providing such a route, but there is no study, of which we are aware, which addresses this
issue in the mouse. We speculate that the increase in 14C-mannitol and 14C-inulin diffusion
observed here in the Phlda2−/+ mutant, in the absence of a change in total Lz surface area
or thickness, is related to a change in the length or radius of such putative routes in the
trophoblast layers. We further speculate that 14C-inulin transfer remaining higher in the
mutant at E19, whereas that of 14C-mannitol is normal at this gestation, is related to the
number of a population of narrower channels, through which most of the diffusion of the
smaller 14C-mannitol molecule takes place, increasing at E16 and returning to normal at
E19, whereas the number of a population of wider channels, through which most of the
14C-inulin diffusion takes place, is increased at E16 and remains so at E19. Heterogenous
channel populations in the hemochorial placenta have previously been suggested [31].
As discussed in [28], the nature of the diffusional route for hydrophilic solutes across the
placenta is a fundamental piece of information lacking in our understanding of placental
exchange physiology; the Phlda2−/+ mutant might provide a useful tool for dissecting the
nature and regulation of this route.
It is tempting to speculate that the increased passive permeability of Phlda2−/+ pla-
centae contributes to the intra-uterine catch-up fetal growth that is observed prior to E19.
Although placental weight reaches a plateau after E16, or even decreases slightly, placental
Lz, including the interchange surface area, continues to expand until term [22]. Placen-
tal passive permeability also increases in absolute terms between E16 and E19 (Figure S1
and [23]). Phlda2−/+ fetuses received an excess of the radioactive labels for their size relative
to Phlda2+/+ controls, strongly suggesting that there is increased flux of nutrients reaching
the fetus. Overall, according to Fick’s Law, the effect of an increased passive permeability
on the transfer of individual solutes will be dependent on maternal/fetal electrochemical
gradients, about which we know little in the mouse. However, to illustrate the point, if we
assume the maternal plasma glucose concentration is higher than in fetal plasma, as it is in
most species, then increased permeability will increase glucose flux to the fetus, in addition
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to that transferred by facilitated diffusion. However, for amino acids where the concen-
tration gradient is usually higher in the fetal plasma than in the maternal plasma (due to
active transport), then increased permeability could actually decrease net amino acid flux
to the fetus, due to increased diffusional back flux in the fetal to maternal direction.
Our study is inconclusive regarding the contribution of the placenta to the reduced
fetal weight observed at E16 in our study and at E17 in [9]. From our stereological studies
and placental transfer studies, we conclude that the transitory reduction in fetal growth
is not caused by reduced transport capacity to the fetus. However, we cannot rule out
other explanations such as increased partitioning of maternal resources to the placenta to
sustain the expansion of the Jz layer, as previously proposed [13]. Indeed, the placenta itself
consumes approximately 35–40% of the oxygen and glucose removed from the maternal
uterine circulation by the feto-placental unit [32–34]. Placental metabolism determines
the types and quantities of nutrients transferred to the fetus [35]. Placental metabolism
depends on the size of placenta and responds to a number of environmental cues, including
diet, hormones and oxygen [36–40]. An increase in placental size overall would put a
greater strain on the maternal nutrient resources, which is limited and known as maternal
constraint [41,42]. Several tissues, especially the liver and kidney, express significant levels
of Phlda2 mRNA [8]. In part, the changes in fetal growth may also relate to altered Phlda2
expression in the fetal tissues, so conditional deletions of fetal and placental Phlada2 would
be needed to differentiate between fetal and placental contribution to the changes in the
fetal growth trajectory. These could be achieved using, for example, the Cyp19-Cre line
that is active in the early diploid trophoblast cells from which both placental Lz and Jz
derive [43].
We have previously shown that the developmental regulation of diffusional exchange
characteristics of the placenta is an important mechanism by which imprinted genes
influence placental nutrient supply and fetal growth (summarized in Table 4). Deletion in
the mouse of the paternally expressed placental-specific Igf2 P0 transcript (Igf2P0+/−) [44]
led to a small-sized placenta and reduced placental passive permeability for three inert
hydrophilic solutes of increasing sizes (14C-mannitol, 51CrEDTA, and 14C-inulin) at E19
of gestation, which was associated with an increase in thickness of the exchange barrier
compared to littermate controls [23] (Table 4). When all Igf2 transcripts were deleted
throughout the conceptus (Igf2null+/−), the increase in the thickness of the barrier was
milder compared to Igf2P0+/− mutants [45] and only the permeability for the largest tracer
(14C-inulin) was significantly reduced at E19 of gestation [45] (Table 4). Interestingly, in
both Igf2 models (Igf2P0+/− and Igf2null+/−) we observed alterations in the transplacental
flux of 14C-methyl-D-glucose and/or 14C-MeAIB, as well as placental expression of amino
acid and glucose transporters [24]. These findings strongly suggest that the small mutant
Igf2P0+/−and Igf2null+/− placentae are capable of functional compensatory adaptations
in response to either increased or decreased fetal demands for growth, respectively [24].
Overexpression of Igf2, achieved through a 13 kb deletion that included the H19 gene and
the H19/Igf2-imprinting control region ICR1 (H19∆13), led to an enlarged placenta, with
pronounced reductions in placental nutrient transfer by the three mechanisms, including
passive permeability, with the amounts of 14C-mannitol and 14C-inulin transferred by the
placenta significantly reduced in mutants at both E16 and E19 [42] (Table 4). In this model of
Igf2 overexpression, the thickness of the exchange barrier in mutants was not different from
control littermates. Rtl1 (retrotransposon-like 1) is a paternally expressed gene that has a
demonstrated role in altering placental passive permeability [46]. Accordingly, paternal
deletion of Rtl1 led to a significant reduction in placental passive permeability for 14C-inulin
at E16, likely explained by areas of placental infarction observed in these mutants [46].
Altogether, these findings show that imprinted genes modify placental passive permeability,
through several possible mechanisms, from regulation of the thickness of exchange barrier
(Igf2P0) and altered number or size of pores (H19/Igf2, and Phlda2 as first demonstrated
here), to developmental defects (Rtl1). To our knowledge, Phlda2 is the only imprinted
gene described so far with a role in modulating maternal-fetal exchange of solutes solely
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by effects on passive permeability. We propose that an important novel function for this
maternally expressed gene is to limit the allocation of maternal resources to the growing
fetus by reducing the permeability characteristics of the placenta. This ‘strategy’ adopted
by Phlda2 is consistent with the general roles played by maternally expressed genes in the
offspring as proposed by the two most widely accepted evolutionary theories of imprinting,
i.e., the kinship and maternal-offspring coadaptation.
Table 4. Effects of deletion of selected imprinted genes on placental transport characteristics at E19 of mouse pregnancy








Transport Placental Size Normal Role of Gene on
Passive Permeability
Reference
MeAIB Glucose Lz Jz





No ∆ ↑ ↓ ↓





Igf2 ↓ ↓ (inulin) ↓ No ∆ ↓ ↓







↑ ↓ (inulin,mannitol) ↓ ↓ ↑ ↑
Increases paracellular pore
characteristics and reduces
TDC through effects on
surface area
[42]
Lz—labyrinthine zone, Jz—junctional zone, No ∆—no change, ↑—increase, ↓—decrease, TDC—theoretical diffusion capacity of the
interhemal membrane, LOI – Loss of Imprinting.
We also note that all imprinted genes that were assessed to date for placental passive
permeability properties in transgenic studies show evidence for impaired exchange of
diffusional characteristics (Rtl1, H19/Igf2, Igf2P0 and now Phlda2—see Table 4). At present,
there is no evidence of interaction of imprinted genes in the regulation of passive per-
meability. However, it has not escaped our attention that the imprinted gene network
(IGN), regulated by the zinc-finger transcription factor PLAGL1 [47], includes IC1 and IC2
genes (e.g., Igf2, H19) but also Rtl1, all of which have a major impact on placenta passive
permeability. Moreover, H19 is a transregulator of the IGN, with the knock-out of H19
causing expression changes in a number of IGN genes (including Rtl1, Igf2 and Cdkn1c) [47].
It will be important to define, in future studies, how many other imprinted genes may play
roles in passive diffusion and perform genetic studies targeted to the placenta to provide
evidence for direct or indirect interactions between IGN genes in the regulation of passive
diffusion. At the moment, we propose that Phlda2 may play a unique and specific role in
the control of pore size/number, but methods to visualize and measure such pores are
urgently needed.
5. Conclusions
Overall, in this study, we filled an important gap in our knowledge about the role
played by the imprinted Phlda2 gene in the placenta. Our results reiterate the important
roles played by the imprinted genes in controlling the exchange characteristics of the mouse
placenta and the complex relationship between these functional properties and the detailed
morphological structure of the interchange layer of placenta. By influencing placental
passive permeability, Phlda2 may play an important role in fine-tuning fetal growth to
reach its genetically determined potential. Further studies are needed to define the specific
molecular mechanisms by which the Phlda2 gene acts on placental passive permeability.
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